These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

546 related items for PubMed ID: 17366287

  • 1. Management of hepatitis C among drug users attending general practice in Ireland: baseline data from the Dublin area hepatitis C in general practice initiative.
    Cullen W, Stanley J, Langton D, Kelly Y, Bury G.
    Eur J Gen Pract; 2007; 13(1):5-12. PubMed ID: 17366287
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Hepatitis C, B, and human immunodeficiency virus infections in illicit drug users in Israel: prevalence and risk factors.
    Loebstein R, Mahagna R, Maor Y, Kurnik D, Elbaz E, Halkin H, Olchovsky D, Ezra D, Almog S.
    Isr Med Assoc J; 2008 Nov; 10(11):775-8. PubMed ID: 19070285
    [Abstract] [Full Text] [Related]

  • 6. HIV/hepatitis coinfection in eastern Europe and new pan-European approaches to hepatitis prevention and management.
    Lazarus JV, Shete PB, Eramova I, Merkinaite S, Matic S.
    Int J Drug Policy; 2007 Oct; 18(5):426-32. PubMed ID: 17854732
    [Abstract] [Full Text] [Related]

  • 7. Methadone maintenance and hepatitis C virus infection among injecting drug users.
    Crofts N, Nigro L, Oman K, Stevenson E, Sherman J.
    Addiction; 1997 Aug; 92(8):999-1005. PubMed ID: 9376782
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Relevance of intravenous cocaine use in relation to prevalence of HIV, hepatitis B and C virus markers among intravenous drug abusers in southern Italy.
    Guadagnino V, Zimatore G, Izzi A, Caroleo B, Rocca A, Montesano F, Costa C, Masciari R, Naso E, Biselli R.
    J Clin Lab Immunol; 1995 Aug; 47(1):1-9. PubMed ID: 8735431
    [Abstract] [Full Text] [Related]

  • 10. Markers and risk factors for HCV, HBV and HIV in a network of injecting drug users in Melbourne, Australia.
    Miller ER, Hellard ME, Bowden S, Bharadwaj M, Aitken CK.
    J Infect; 2009 May; 58(5):375-82. PubMed ID: 19328555
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [A study on the prevalence rates of human immunodeficiency virus, hepatitis B virus and hepatitis C virus infections in intravenous drug users].
    Wang YC, Xu SH, Li XH, Song AJ, Jia XR, Zhuang H.
    Zhonghua Liu Xing Bing Xue Za Zhi; 2006 Sep; 27(9):777-9. PubMed ID: 17299963
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Prevalence of HIV, hepatitis B, C and G virus infections among injecting drug users on methadone maintenance treatment in Maribor.
    Baklan Z, Gorisek JR, Poljak M, Pisec A.
    Wien Klin Wochenschr; 2004 Sep; 116 Suppl 2():5-7. PubMed ID: 15506302
    [Abstract] [Full Text] [Related]

  • 15. Hepatitis C infection among intravenous drug users attending therapy programs in Cyprus.
    Demetriou VL, van de Vijver DA, Hezka J, Kostrikis LG, Cyprus IVDU Network, Kostrikis LG.
    J Med Virol; 2010 Feb; 82(2):263-70. PubMed ID: 20029809
    [Abstract] [Full Text] [Related]

  • 16. Association of HCV and HBV markers in Spanish HIV-seropositive patients in relation to risk practices.
    Rodríguez-Méndez ML, González-Quintela A, Aguilera A, Carballo E, Barrio E.
    Hepatogastroenterology; 2003 Feb; 50(54):2093-7. PubMed ID: 14696471
    [Abstract] [Full Text] [Related]

  • 17. Drug users attending general practice in Eastern Regional Health Authority (ERHA) area.
    Cullen W, Bury G, Barry J, O'Kelly F.
    Ir Med J; 2000 Oct; 93(7):214-7. PubMed ID: 11142958
    [Abstract] [Full Text] [Related]

  • 18. [Factors related to screening of hepatitis C virus in general medicine].
    Rotily M, Loubière S, Prudhomme J, Portal I, Tran A, Hofliger P, Valla D, Moatti JP.
    Gastroenterol Clin Biol; 2002 Mar; 26(3):261-9. PubMed ID: 11981471
    [Abstract] [Full Text] [Related]

  • 19. Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales.
    Sutton AJ, Gay NJ, Edmunds WJ, Hope VD, Gill ON, Hickman M.
    BMC Infect Dis; 2006 Jun 08; 6():93. PubMed ID: 16762050
    [Abstract] [Full Text] [Related]

  • 20. Antiretroviral adherence and HIV treatment outcomes among HIV/HCV co-infected injection drug users: the role of methadone maintenance therapy.
    Palepu A, Tyndall MW, Joy R, Kerr T, Wood E, Press N, Hogg RS, Montaner JS.
    Drug Alcohol Depend; 2006 Sep 15; 84(2):188-94. PubMed ID: 16542797
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.